Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Medpace Holdings Inc (MEDP)
:MEDP
Holding MEDP?
Track your performance easily
MEDP Stock Chart & Stats
Day’s Range― - ―
52-Week Range$286.76 - $459.77
Previous CloseN/A
Volume64.09K
Average Volume (3M)241.33K
Market Cap
$10.47B
Enterprise Value$10.21B
Total Cash (Recent Filing)$37.10M
Total Debt (Recent Filing)$151.27M
Price to Earnings (P/E)29.5
Beta1.54
Next Earnings
Feb 10, 2025EPS Estimate
2.94Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)11.42
Shares Outstanding31,081,600
10 Day Avg. Volume231,680
30 Day Avg. Volume241,330
Standard Deviation0.12
R-Squared0.36
Alpha0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)5.06
Price to Cash Flow (P/CF)17.60
P/FCF Ratio18.90
Enterprise Value/Market Cap0.97
Enterprise Value/Revenue4.93
Enterprise Value/Gross Profit19.46
Enterprise Value/Ebitda21.32
Forecast
1Y Price Target
$343.67Price Target Upside1.87% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
Medpace Holdings News
Bulls Say, Bears Say
Bulls Say
Cash FlowFree cash flow was strong, surpassing consensus estimates by a significant margin, indicating robust cash generation.
Financial PerformanceMEDP's earnings per share and EBITDA significantly exceeded analyst expectations, driven by better-than-expected cost management.
ProfitabilityEBITDA margin of 22.3% exceeded expectations, demonstrating strong cost management and profitability.
Bears Say
Biotech DemandMEDP's results aligned with commentary indicating challenged biotech demand, with lower gross additions to backlog and elevated cancellations.
Client Funding ChallengesThere’s concern over how much backlog remains at risk due to funding challenges and conjecture over the quality of clients in backlog.
Financial PerformanceThe sequential decline in the book-to-bill ratio and a year-over-year decline in bookings are worse than investor expectations.
---
Ownership Overview
33.05% Insiders
25.66% Mutual Funds
1.04% Other Institutional Investors
19.96% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MEDP FAQ
What was Medpace Holdings Inc’s price range in the past 12 months?
Medpace Holdings Inc lowest stock price was $286.75 and its highest was $459.77 in the past 12 months.
What is Medpace Holdings Inc’s market cap?
Medpace Holdings Inc’s market cap is $10.47B.
When is Medpace Holdings Inc’s upcoming earnings report date?
Medpace Holdings Inc’s upcoming earnings report date is Feb 10, 2025 which is in 19 days.
How were Medpace Holdings Inc’s earnings last quarter?
Medpace Holdings Inc released its earnings results on Oct 21, 2024. The company reported $3.01 earnings per share for the quarter, beating the consensus estimate of $2.771 by $0.239.
Is Medpace Holdings Inc overvalued?
According to Wall Street analysts Medpace Holdings Inc’s price is currently Undervalued.
Does Medpace Holdings Inc pay dividends?
Medpace Holdings Inc does not currently pay dividends.
What is Medpace Holdings Inc’s EPS estimate?
Medpace Holdings Inc’s EPS estimate is 2.94.
How many shares outstanding does Medpace Holdings Inc have?
Medpace Holdings Inc has 31,081,600 shares outstanding.
What happened to Medpace Holdings Inc’s price movement after its last earnings report?
Medpace Holdings Inc reported an EPS of $3.01 in its last earnings report, beating expectations of $2.771. Following the earnings report the stock price went down -7.475%.
Which hedge fund is a major shareholder of Medpace Holdings Inc?
Currently, no hedge funds are holding shares in MEDP
---
Medpace Holdings Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$343.67 (1.87% Upside)
$343.67 (1.87% Upside)
Blogger Sentiment
Bullish
MEDP Sentiment 70%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 147.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▲ 1.2%
Last 30 Days ▼ 3.3%
Last 30 Days ▼ 3.3%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
18.42%
12-Months-Change
Fundamentals
Return on Equity
54.06%
Trailing 12-Months
Asset Growth
40.18%
Trailing 12-Months
Company Description
Medpace Holdings Inc
Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in July 1992 and is headquartered in Cincinnati, OH.
---
MEDP Company Deck
---
MEDP Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflects a mixed performance. While there is strong revenue growth, improved EBITDA margins, and increased cash flow, the company is experiencing challenges with elevated backlog cancellations, decreased net new business awards, and a decline in RFPs. The sentiment is balanced with significant positives but also notable negatives.Read More>---
MEDP Revenue Breakdown
98.00% U.S.
2.00% Other
---
MEDP Stock 12 Month Forecast
Average Price Target
$343.67
▲(1.87% Upside)
Technical Analysis
Charles River Labs
―
IQVIA Holdings
―
QuidelOrtho
―
Laboratory Corporation of America Holdings
―
Veeva Systems
―
Alnylam Pharma
―
Best Analysts Covering MEDP
1 Year
1 Year Success Rate
1/3 ratings generated profit
1 Year Average Return
-3.47%
assigned a buy rating 3 months ago
Copying Charles Rhyee's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -3.47% per trade.
---